In the News
CD&R, Merck, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Platform
Oncology data and informatics platform M2GEN has announced a significant investment by three major venture investment firms: Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The investment will recapitalize M2GEN to accelerate the growth of M2GEN’s...
GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
GRAIL has announced that it is joining forces with AccessHope™ to offer a world-class service experience to people who use Galleri™, GRAIL’s first-of-kind multi-cancer early detection blood test. This collaboration is part of GRAIL’s effort to help patients and their healthcare providers achieve favorable outcomes by...
The Apple Watch in clinical trials: Current uses and future possibilities
The use of wearables has been of great benefit to clinical trials: researchers can gather far more data, more often, more objectively, and more easily than ever before. And over the past year, digital tools for remote measurement made it possible to continue trials that otherwise would have been halted. Of all these...
GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test
GRAIL today announced a partnership with the health system Providence to offer Galleri, GRAIL’s multi-cancer early detection blood test. Providence, based in Renton, Wash., will offer Galleri as a complement to recommended single cancer screening tests. Providence will initially deploy Galleri at its California,...
Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test
GRAIL has entered an agreement with Quest Diagnostics to provide phlebotomy services in support of its multi-cancer early detection blood test. The test, called Galleri, is expected to go to market in the second quarter after its PATHFINDER multi-site interventional study. Under the agreement, Quest’s phlebotomy...
Truveris Expands Leadership Team With Key Appointments
Truveris, a digital health company focused on reducing costs and improving access in pharmacy, announced that it has bolstered its leadership team with several key hires and internal appointments. Under the leadership of CEO Jeff Eberle, Truveris has assembled a seasoned team of industry veterans to drive innovation...
Wellness brand Hims & Hers moving deeper into healthcare with Privia Health partnership
Hims launched in 2017 as a men’s health company, selling just a few products designed to help men suffering from erectile dysfunction or hair loss. Now the company has expanded greatly, adding a women’s health business called Hers, focused on birth control, sexual health, and skin and hair care. But even then, the...
Hims & Hers Health, Inc. Closes Business Combination and Wil Begin Trading on the New York Stock Exchange
Hims & Hers Health Inc (“Hims & Hers”), a multi-specialty telehealth platform, announced that it has closed its business combination with Oaktree Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management. The transaction, which was approved by Oaktree’s...
Aledade Raises $100 Million Series D to Help More Primary Care Practices Thrive in Value-Based Care
Aledade recently closed a $100 million Series D funding round following a year of significant growth for its national network of risk-taking primary care practices. Returning investor Meritech Capital led the round, which included new growth investors Tiger Global Management and IVP, and returning investor OMERS...
Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month
Kyruus announced that it has expanded its patient access platform to enable customers to offer online consumer scheduling for COVID-19 vaccine visits. The vaccine scheduling capabilities are available within the company’s award-winning online scheduling solution. Almost 10 health systems have already activated...
Press Releases
Hims & Hers Expands Mental Health Offerings to Include Individual Online Therapy
McKesson Ventures portfolio company Hims & Hers recently announced that it has expanded its mental health offerings to include individual online therapy. Built to complement the platform’s existing services including access to online psychiatry and free,...
Empowerment Model: A New Partnership Model for Maximum Efficiency, Cost Savings, and Control, Upcoming Webinar Hosted by Xtalks
Two experts from Clinical Ink will present a webinar on the benefits of subscription models for clinical trials on July 13, 2021, at 11 a.m. ET. In the webinar, hosted by Xtalks, Clinical Ink Senior Director, Outcome Solutions Kim Romanello; and Manager, Product...
HumanFirst joins the FDA, HHS and more than 20 organizations and leading health companies to launch the Digital Health Measurement Collaborative Community (DATAcc)
More than 20 organizations and companies, including McKesson Ventures portfolio companies Aetion, Evidation Health, and Xealth, have joined together with other members of the Digital Medicine Society (DiMe) to create the Digital Health Measurement Collaborative...
PicnicHealth Partners with Komodo Health to Enrich Its Research Platform Utilizing Real-World Patient Data
Komodo Health and PicnicHealth have announced a partnership to support real-world evidence research programs for complex chronic illnesses like multiple sclerosis and hemophilia. With this partnership, PicnicHealth will enrich its database of de-identified patient...
Geisinger Health Plan Makes Searching for a Provider Easier With Kyruus-HealthSparq Integration
Geisinger Health Plan has expanded its partnership with HealthSparq, a healthcare guidance and transparency technology company serving health plans, and its parent company, Kyruus. GHP is the first health plan to use HealthSparq’s new Path to Care solution to power...